Plumbline Life Sciences Company Description

Plumbline Life Sciences, Inc. engages in the development and sale of DNA medicines for animals.

Its products include LifeTide SW5, a pig immune-modulator; PLS-ASF, a swine fever DNA vaccine; PLS-FMD; PLS-B3000, a dairy cattle DNA therapy; PLS-IF1000, a FMD vaccine; PLS-H1000, a horse laminitis therapy; PLS-D5000, a dog DNA cancer immunotherapy; PLS-D1000 for age related immune deficiency in senior dogs; and PLS-C2000 for age related immune deficiency in senior cats.

Plumbline Life Sciences, Inc. was founded in 2014 and is headquartered in Seoul, South Korea.

Plumbline Life Sciences, Inc.

Country	South Korea
Founded	2014
Industry	Biological Products, Except Diagnostic Substances
CEO	Anthony K. Kim

Contact Details

Address: 18, Seocho-daero 34-gil Seoul, 06661 South Korea
Phone	82 2 582 3540
Website	plumblinels.com

Stock Details

Ticker Symbol	222670
Exchange	Korea New Exchange
Reporting Currency	KRW
SIC Code	2836

Key Executives

Name	Position
Anthony K. Kim	Chief Executive Officer
Youngki Lee	Chief Financial Officer